THE INFLUENCE OF CYP2C9 POLYMORPHISM ON ANTICOAGULATION WITH WARFARIN IN PATIENTS WITH CEREBROVASCULAR DISEASE
| dc.contributor.author | Atasoy, E. B. | |
| dc.contributor.author | Celebi, A. | |
| dc.contributor.author | Hakyemez, A. | |
| dc.contributor.author | Kaymaz, C. | |
| dc.contributor.author | Kurtuncu, M. | |
| dc.date.accessioned | 2025-10-16T15:37:26Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | 15th Congress of the European-Federation-of-Neurological-Societies (EFNS), Budapest, HUNGARY, SEP 10-13, 2011 | |
| dc.identifier.other | WOS:000294806600182 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/9685 | |
| dc.publisher | WILEY-BLACKWELL | |
| dc.source | EUROPEAN JOURNAL OF NEUROLOGY | |
| dc.title | THE INFLUENCE OF CYP2C9 POLYMORPHISM ON ANTICOAGULATION WITH WARFARIN IN PATIENTS WITH CEREBROVASCULAR DISEASE | |
| dc.type | Meeting Abstract |